2025-09-11T13:57:59+00:00 2024-12-31 440160260 Forvis Mazars LLP 135 West 50th Street New York NY 10020 990 2024-01-01 132890727 Guttmacher Institute Inc GUTT 2122481111 125 MAIDEN LANE 7TH FLOOR NEW YORK NY 10038 Jonathan Wittenberg Co-CEO and President 2122481111 2025-09-11 true Aaron Shapiro P01333816 2128127000 2025-09-11 2024 2025-03-06 01:10:19Z Jonathan Wittenberg 125 MAIDEN LANE 7TH FLOOR NEW YORK NY 10038 65781703 false X WWW.GUTTMACHER.ORG X 1977 NY THE INSTITUTE IS A LEADING RESEARCH AND POLICY ORGANIZATION COMMITTED TO ADVANCING SEXUAL AND REPRODUCTIVE HEALTH AND RIGHTS IN THE UNITED STATES AND GLOBALLY. 23 23 145 23 0 25895580 23313235 14325 14211 1987027 2863930 39771 306837 27936703 26498213 0 0 19061529 22784304 0 2259459 12883513 12497751 31945042 35282055 -4008339 -8783842 73164413 64447543 13624813 12602885 59539600 51844658 THE INSTITUTE IS A LEADING RESEARCH AND POLICY ORGANIZATION COMMITTED TO ADVANCING SEXUAL AND REPRODUCTIVE HEALTH AND RIGHTS IN THE UNITED STATES AND GLOBALLY. false false 16508065 Research - See Schedule O 6697628 14211 Public Education - See Schedule O 3489761 Public Policy - See Schedule O 26695454 true true false true false false false false false true true false false true true false true false false false false false false false false false false false false true false false false false false false false false false false true false false false false false false false false false true 83 0 145 true false false false false false false false false false false false false X 23 23 false false false false false false false true true false false false true true true true true true true true false false CA FL GA AL HI IL KS KY MD MA MI MN MS NH NJ NM NY NC OR PA RI SC TN UT VA AR WV WI X Jonathan Wittenberg 2122481111 125 MAIDEN LANE 7TH FLOOR NEW YORK NY 10038 CAROLINE GREENE TREASURER 0.9 0.0 X X 0 0 0 MUGDHA MOKASHI SECRETARY 0.7 0.0 X X 0 0 0 PAMELA MERRITT IMMEDIATE PAST CHAIR 1.2 0.0 X X 0 0 0 WENDY BOSTWICK BOARD CHAIR 0.8 0.0 X X 0 0 0 ALEX EZEH BOARD MEMBER 0.9 0.0 X 0 0 0 ALLANA WELCH CHAIR OF AUDIT COMMITTEE 0.7 0.0 X 0 0 0 BARBARA SINGHAUS BOARD MEMBER (THRU 06/24) 0.7 0.0 X 0 0 0 BENJAMIN KAHRL BOARD MEMBER (THRU 06/24) 0.5 0.0 X 0 0 0 BETH FREDRICK BOARD MEMBER 0.2 0.0 X 0 0 0 CAROLYN FLOREY BOARD MEMBER 0.2 0.0 X 0 0 0 DEBRA FINE BOARD MEMBER 0.8 0.0 X 0 0 0 ERNESTINA COAST BOARD MEMBER (THRU 06/24) 0.6 0.0 X 0 0 0 FAJER SAEED EBRAHIM CHAIR OF DEVELOPMENT COMMITTEE 0.8 0.0 X 0 0 0 FAYSAL EL KAK BOARD MEMBER 0.2 0.0 X 0 0 0 GAIL BAITY MEMBER AT LARGE 1.0 0.0 X 0 0 0 JESSICA PINKNEY GIL CHAIR, NOMINATING & GOVERNANCE 0.8 0.0 X 0 0 0 KELLI MURRAY BOARD MEMBER 0.7 0.0 X 0 0 0 LAURA PHILIPS BOARD MEMBER (THRU 06/24) 0.6 0.0 X 0 0 0 LIDA COLEMAN BOARD MEMBER (THRU 06/24) 0.3 0.0 X 0 0 0 LILIAN ABRACINSKAS BOARD MEMBER 0.5 0.0 X 0 0 0 LUBNA BHAYANI BOARD MEMBER 0.2 0.0 X 0 0 0 MELISSA MURRAY BOARD MEMBER (THRU 06/24) 0.0 0.0 X 0 0 0 MICHAEL KLEIN BOARD MEMBER (THRU 06/24) 1.0 0.0 X 0 0 0 NOZER SHERIAR MEMBER AT LARGE 0.8 0.0 X 0 0 0 PAMELA SCHNEIDER BOARD MEMBER 0.2 0.0 X 0 0 0 PAULA AVILA-GUILLEN BOARD MEMBER 0.2 0.0 X 0 0 0 SABARATNAM ARULKUMARAN BOARD MEMBER 0.6 0.0 X 0 0 0 SUSAN EKBERG STIRITZ BOARD MEMBER 0.2 0.0 X 0 0 0 SUSAN FRELICH APPLETON BOARD MEMBER 0.7 0.0 X 0 0 0 TRACIE GREGORY GOFFE BOARD MEMBER 0.2 0.0 X 0 0 0 ALETHA AKERS VP FOR RESEARCH (THRU 09/24) 35.0 0.0 X 269787 0 21605 DESTINY LOPEZ ACTING CEO 35.0 0.0 X 325331 0 14415 JONATHAN WITTENBERG ACTING CEO 35.0 0.0 X 373949 0 84305 KELLY BADEN VP FOR PUBLIC POLICY 35.0 0.0 X 283631 0 39000 MAIBE PONET VP FOR COMMUNICATIONS 35.0 0.0 X 270473 0 80207 MAUREEN BURNLEY VP FOR FINANCE & ADMIN. 35.0 0.0 X 286551 0 66842 SUSHEELA SINGH DISTINGUISHED SCHOLAR & VP 35.0 0.0 X 375922 0 83742 WENDY SEALEY VICE PRESIDENT FOR DEVELOPMENT 35.0 0.0 X 278283 0 74477 JENNIFER FROST PRINCIPAL RESEARCH SCIENTIST 35.0 0.0 X 243520 0 37248 KATHLEEN RANDALL DIRECTOR OF PRODUCTION 35.0 0.0 X 248492 0 62832 KATHRYN KOST DIRECTOR OF DOMESTIC RESEARCH 35.0 0.0 X 271260 0 79412 ONIKEPE OWOLABI DIRECTOR OF INTERNATIONAL RESEARCH 35.0 0.0 X 227293 0 69558 RACHEL JONES PRINCIPAL RESEARCH SCIENTIST 35.0 0.0 X 227669 0 39088 3682161 0 752731 73 false true false AFRICAN POPULATION & HEALTH RESEARCH CTR MANGA CLOSE KIRAWA ROAD NAIROBI KE 00100 PRGRM SUBCONTRACTOR 788373 ST PAUL INSTITUTE FOR REPRODUCTIVE HEALTH RIGHTS 2PXG9PG GULELE SUB-CITY ADDIS ABABA ET PRGRM SUBCONTRACTOR 412000 CIVITAS PUBLIC AFFAIRS GROUP LLC 409 7th Street NW Suite 350 WASHINGTON DE 20004 PRGRM SUBCONTRACTOR 306099 PMO ADVISORY LLC 41 WATCHUNG PLAZA SUITE 186 MONTCLAIR NJ 07042 MAMAGEMENT CONSULTING 271688 UMATI UMATI Head Quarter Upanga Maliki Street POBox 1372 Daressalaam TZ PRGRM SUBCONTRACTOR 260566 19 7311902 16001333 5010998 23313235 PUBLICATIONS 900099 14211 14211 0 0 0 0 14211 1447117 1447117 16625 16625 0 0 40700303 39283490 1416813 0 1416813 1416813 0 OTHER 900099 290212 290212 0 0 0 0 290212 26498213 14211 0 3170767 X 2928520 2241640 497877 189003 15047473 11517093 2559437 970943 1225884 938794 207885 79205 2325198 1781025 393803 150370 1257229 962798 213201 81230 299428 299428 108360 108360 14347 14347 147933 147933 6552267 5602371 593678 356218 512085 318485 101462 92138 692349 244543 373618 74188 1585508 1280452 203289 101767 1239108 883431 351044 4633 188904 134681 53517 706 704736 539393 119870 45473 126089 101829 16167 8093 MISCELLANEOUS 233040 127623 78452 26965 PRINTING AND ARTWORK 93597 6949 8121 78527 0 0 0 0 35282055 26695454 6327142 2259459 1544749 2240459 20271458 8648926 2318388 4805228 517213 505887 0 0 0 0 216285 45446 20643779 12644982 8371636 7998797 35700647 36763169 0 0 4224037 3439631 73164413 64447543 1635654 1932074 0 0 6859361 6343753 5129798 4327058 13624813 12602885 X 34220325 27469111 25319275 24375547 59539600 51844658 73164413 64447543 X -8783842 1095328 -105794 99366 X false true true true true X 18034032 33703442 32442037 25895580 23313235 133388326 0 0 18034032 33703442 32442037 25895580 23313235 133388326 54886107 78502219 526871 593146 915135 1693499 1463742 5192393 0 14057 15511 143966 24587 290212 488333 139069052 118713 0.56448 0.54265 X Schedule A, Part II, Line 10 Other Income DESCRIPTION - OTHER INCOME, COLUMN A - 14057.0, COLUMN B - 15511.0, COLUMN C - 143966.0, COLUMN D - 24587.0, COLUMN E - 290212.0, COLUMN F - 488333.0; RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 14347 14347 35267708 35282055 1000000 0 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 9539 4710 7584 14347 36180 250000 250000 250000 250000 1000000 1500000 0 0 8791550 1139067 276827 9653790 7736954 1324026 269430 8791550 9645224 -1638150 270120 7736954 8833429 1070119 258324 9645224 7888871 1207790 263232 8833429 0.0 0.4971 0.5029 false false 11966673 5194188 6772485 2621547 2247492 374055 3840432 3445708 394724 2215127 1757594 457533 7998797 Right-of-use assets - operating leases 3265514 SECURITY DEPOSITS 157018 OTHER ASSETS 17099 3439631 Federal Income Taxes OPERATING LEASE LIABILITIES 3825005 POSTRETIREMENT BENEFITS PAYABLE 502053 4327058 27544974 1095328 99366 1194694 26350280 147933 0 147933 26498213 35134122 0 0 35134122 147933 0 147933 35282055 Schedule D, Part X, Line 2 ASC 740 FOOTNOTE MANAGEMENT HAS EVALUATED THEIR INCOME TAX POSITIONS UNDER THE GUIDANCE INCLUDED IN ASC 740. BASED ON THEIR REVIEW, MANAGEMENT HAS NOT IDENTIFIED ANY MATERIAL UNCERTAIN TAX POSITIONS TO BE RECORDED OR DISCLOSED IN THE FINANCIAL STATEMENTS. Schedule D, Part V, Line 4 Intended uses of endowment funds GUTTMACHER'S ENDOWMENT PROVIDES SUPPORT FOR THE INSTITUTE'S ANNUAL OPERATIONS. THE BOARD HAS HISTORICALLY APPROVED 3% OF THE AVERAGE OF THE PRIOR TWELVE QUARTERS TO BE SPENT IN THE CURRENT FISCAL YEAR FOR GENERAL OPERATIONS. THE INSTITUTE'S ENDOWMENTS CONSIST OF A DONOR-RESTRICTED ENDOWMENT FUND TO BE USED FOR GENERAL OPERATIONS AND ENDOWMENT GIFTS TOTALING $1 MILLION TO BE USED FOR BIXBY FELLOWSHIPS. Schedule D, Part XI, Line 2(d) Other revenues in audited financial statements not in form 990 ADJUSTMENT TO MINIMUM POSTRETIREMENT BENEFIT LIABILITY - 99366 X X X false false false false false false false false false SUSHEELA SINGH DISTINGUISHED SCHOLAR & VP 369941 0 0 0 5981 0 37985 0 45757 0 459664 0 0 0 JONATHAN WITTENBERG ACTING CEO 362422 0 0 0 11527 0 38548 0 45757 0 458254 0 0 0 DESTINY LOPEZ ACTING CEO 325331 0 0 0 0 0 13010 0 1405 0 339746 0 0 0 MAUREEN BURNLEY VP FOR FINANCE & ADMIN. 277449 0 0 0 9102 0 29565 0 37277 0 353393 0 0 0 KELLY BADEN VP FOR PUBLIC POLICY 280366 0 0 0 3265 0 23335 0 15665 0 322631 0 0 0 WENDY SEALEY VICE PRESIDENT FOR DEVELOPMENT 269370 0 0 0 8913 0 28720 0 45757 0 352760 0 0 0 MAIBE PONET VP FOR COMMUNICATIONS 253742 0 0 0 16731 0 24915 0 55292 0 350680 0 0 0 ALETHA AKERS VP FOR RESEARCH (THRU 09/24) 265921 0 0 0 3866 0 20074 0 1531 0 291392 0 0 0 KATHRYN KOST DIRECTOR OF DOMESTIC RESEARCH 249639 0 0 0 21621 0 29288 0 50124 0 350672 0 0 0 KATHLEEN RANDALL DIRECTOR OF PRODUCTION 241430 0 0 0 7062 0 25555 0 37277 0 311324 0 0 0 JENNIFER FROST PRINCIPAL RESEARCH SCIENTIST 243520 0 0 0 0 0 24284 0 12964 0 280768 0 0 0 RACHEL JONES PRINCIPAL RESEARCH SCIENTIST 221104 0 0 0 6565 0 23423 0 15665 0 266757 0 0 0 ONIKEPE OWOLABI DIRECTOR OF INTERNATIONAL RESEARCH 216581 0 0 0 10712 0 23801 0 45757 0 296851 0 0 0 7 5010998 Other - sale price false true false Schedule M, Part I Explanations of reporting method for number of contributions Securities - Publicly traded - The organization is reporting the number of contributions. Form 990, Part III, Line 4a Research In 2024, Guttmacher once again generated a wide range of timely, high-quality, and policy-relevant research that was published in respected scientific journals and was influential in shaping policy debates. Our Research Division continued to produce monthly abortion data for the US with national and state estimates of the number of clinician-provided abortions. This widely cited study is meeting the need for frequent data reports that capture the effects of the rapidly changing state abortion policy landscape and how bans and other restrictions are impacting individuals who are seeking abortion care. In 2024, we also completed our first pilot study of online access to medication abortion, fielding new approaches to capture abortions individuals are self-managing via online resources. We also released new findings on provision of care to family planning patients from our National Survey of Family Planning Providers, including findings from our companion qualitative study with providers of this care to better understand the challenges they are grappling with as the ripple effects of abortion restrictions impact the provision of sexual and reproductive health care more widely. We published findings from the Reproductive Health Impact Study (RHIS), a multiyear project that collected longitudinal data and analyzed the effects of federal and state policies on publicly funded family planning care in the U.S. The study, which focused on Arizona, Iowa, New Jersey and Wisconsin, documented the impact of these policies on access to contraceptive and other reproductive health services, as well as disruptions in contraceptive care and sexual and reproductive care delivery caused by barriers to publicly funded services. Globally, we produced two analyses showing the importance of continued investment into overseas development assistance for family planning by donor governments, including one that Dutch advocates used to forestall damaging funding cuts in the Netherlands, and released new evidence showing the global relationship between greater gender inequality and higher unintended pregnancy rates. We also launched new estimates of the prevalence of abortion and unintended pregnancy in Pakistan, a critical update to inform government decision making since the last study was conducted ten years ago, and new data on the implementation of abortion law reform in Argentina. In addition, we continued to support researchers within our network of partners in Tanzania, Ethiopia and Nigeria to conduct research and publish and disseminate data on sexual reproductive health and rights from their countries as part of our capacity-strengthening program. This work culminated in the November launch of a new coalition: the African Coalition on Research and Communication for Abortion. Form 990, Part III, Line 4b Communications & Publications (C&P) The Institute shaped and informed public debate throughout 2024, as evidenced by the significant coverage our work received in major media outlets, and citations of our work by advocates, policymakers and partners at the state, US national and country levels. The C&P Team strategically disseminated the Institute's evidence and analyses in a range of formats and across a multitude of platforms, targeting key stakeholders and influencers, including advocates, health care providers, policymakers and their staff, media and the scientific community. Building on the work we began in 2023 focusing on the enormous harm caused by the Dobbs decision overturning Roe v Wade, our team developed an interactive dashboard featuring the latest national and state data from the Monthly Abortion Provision Study and policy information gathered by our state policy colleagues, designed to make the findings more accessible than ever. Since its inception, the provision study, and now the web-based dashboard visualizing its outputs, has rapidly become a widely used resource for anyone trying to understand the impact that the Dobbs decision has had on abortion access in the United States. Furthermore, our media relations effort continued to deliver significant impact. Our team sent out 85 news releases to our full press list, in addition to numerous individual and tailored messages; responded to about 800 media requests; and helped to achieve about 20,500 mentions of the Institute and its work in news stories, including numerous articles and segments throughout the year in leading outlets like The New York Times, The Washington Post, USA Today, Associated Press, Reuters and The Guardian, as well as top-tier broadcasters like NPR, NBC News, ABC News, CBS News, and numerous regional, state and local news outlets. Social media channels were another focal point of our work: We kept our more than 100,000 followers across Twitter, Instagram, Facebook and LinkedIn informed with a steady stream of timely posts and impactful graphics and short videos. Finally, our website received nearly 2.3 million page views in 2024. Our Global Communications team continued to focus on capacity-strengthening initiatives aimed at supporting partners in low- and middle-income countries in translating evidence into programmatic and policy change. In 2024, we conducted capacity strengthening workshops in Uganda, Mozambique and Nigeria, and worked closely with partners in Kenya, Sierra Leone, Liberia, Argentina, Ethiopia and elsewhere to plan and develop capacity strengthening activities for our partners and their networks. Global Communications also worked with partners in Argentina, Bangladesh, Pakistan and Colombia to disseminate new research documenting attitudes about abortion care and client experiences seeking abortion. We also launched our updated Family Planning Investment Impact Calculator-a tool to help funders understand the impact of their family planning investments-in time for the UN General Assembly in September 2024. In addition to our externally facing programmatic work, C&P led an Institute-wide rebranding process, designed to update our look and feel to better reflect our organizational identity. As part of this process, we updated our logo, refreshed colors and visuals across all platforms, and introduced a new tagline: "Center facts. Shape policy. Advance sexual and reproductive rights."-which reflects our commitment to defending facts and generating evidence to support sexual and reproductive health and rights in a world riddled with fake news and misinformation. Form 990, Part III, Line 4c Public Policy Guttmacher's public policy division spent 2024 equipping lawmakers, advocates, and allies with critical information to ensure evidence drove policy change at the state, national and global levels. The Institute's Policy team closely tracked state and national policies and offered comprehensive and incisive analyses and resources to make sense of a fast-changing and complicated landscape. We continuously refined our interactive map of state laws to reflect real-time policy changes and new policy innovations. The Institute's experts were cited widely in prominent media outlets throughout the year as journalists and the public sought to make sense of the chaotic legal landscape.As the Institute released dynamic and timely new data, our Policy Division worked to integrate the data into the broader work of the reproductive health, rights and justice field through collaborations, webinars, lawmaker briefings, and reports.In 2024, Guttmacher also launched the Policy Innovation Hub, a network of experts and academics from around the country who are partnering to more deeply understand the landscape of abortion access in the US and are co-creating resources and policy concepts to mitigate the harms caused by the Supreme Court's Dobbs decision. Guttmacher also promoted access to sexual and reproductive health care at the global level, working to ensure the Guttmacher-Lancet Commission's inclusive vision for sexual and reproductive health and rights was front and center by leveraging high level events and equipping UN partners and other spokespeople with key evidence and policy recommendations. Guttmacher co-hosted the second Green Wave Gathering, bringing Latin American and US advocates and experts together to share lessons beyond borders to improve abortion access. Guttmacher continued detailing the benefits of current and increased investment in U.S. assistance for family planning and reproductive health programs around the world. Form 990, Part VI, Line 11b Review of form 990 by governing body THE AUDIT COMMITTEE IS RESPONSIBLE FOR REVIEWING AND APPROVING THE 990 BEFORE SUBMISSION. IF THERE ARE ANY QUESTIONS, THEY ARE DISCUSSED WITH THE TAX PREPARER AND RESOLVED TO THE COMMITTEE'S SATISFACTION. ONCE THE AUDIT COMMITTEE HAS SIGNED OFF, THE 990 IS EMAILED TO ALL BOARD MEMBERS AND THEY ARE ASKED TO CONFIRM THAT THEY HAVE RECEIVED THE FORM 990. Form 990, Part VI, Line 12c Conflict of interest policy OFFICERS AND DIRECTORS ARE REQUIRED TO REVIEW, DISCLOSE POTENTIAL CONFLICTS, AND SIGN THE CONFLICT OF INTEREST POLICY ANNUALLY. THE AUDIT COMMITTEE GATHERS ALL MATERIAL FACTS CONCERNING ANY DISCLOSED CONFLICTS. THE INFORMATION IS PROVIDED TO THE BOARD OF DIRECTORS IF THERE IS A CONFLIECT. IF NECESSARY, THE BOARD VOTES UPON THE APPROPRIATE ACTION WHILE THE INTERESTED PERSON IS EXCUSED. Form 990, Part VI, Line 15a Process to establish compensation of top management official AN EXECUTIVE COMPENSATION COMMITTEE, CONSISTING OF THE BOARD CHAIR, THE FINANCE COMMITTEE CHAIR, AND THE IMMEDIATE PAST BOARD CHAIR, SETS COMPENSATION FOR THE CEO AND REVIEWS COMPENSATION FOR ALL OTHER OFFICERS (I.E. VICE PRESIDENTS). THESE INDIVIDUALS EXERCISE SUBSTANTIAL INFLUENCE OVER THE AFFAIRS OF THE INSTITUTE AND ARE, AS SUCH, DISQUALIFIED PERSONS WITHIN THE MEANING OF SECTION 4958(F)(1) OF THE INTERNAL REVENUE CODE. THE EXECUTIVE COMPENSATION COMMITTEE'S PRIMARY PURPOSE IS TO ENSURE THAT EXECUTIVE COMPENSATION PACKAGES REPRESENT REASONABLE REMUNERATION FOR THE SERVICES PREFORMED AND TO ENSURE COMPLIANCE WITH ALL APPLICABLE FEDERAL, STATE AND LOCAL LAWS. PRIOR TO THE NOVEMBER BOARD MEETING, THE COMMITTEE REVIEWS COMPENSATION FOR SENIOR EXECUTIVES AT COMPARABLE NON-PROFIT ORGANIZATIONS, WITH STAFFING LEVELS AND BUDGETS ON PAR WITH THOSE OF THE INSTITUTE, AND WHICH CONDUCT ACTIVITIES SIMILAR IN SCOPE AND PURPOSE TO THOSE OF THE INSTITUTE, IN ORDER TO BENCHMARK OUR COMPENSATION PRACTICES FOR OFFICERS. THE COMMITTEE MAY ALSO REVIEW SURVEYS COMPILED BY INDEPENDENT FIRMS AND OTHER ORGANIZATIONS' PUBLIC DOCUMENTATION OF SALARY PRACTICES. THE COMMITTEE REPORTS ITS COMPENSATION DETERMINATIONS ANNUALLY TO THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE AND THE BOARD OF DIRECTORS MUST APPROVE THE CEO COMPENSATION PACKAGE AND BE INFORMED OF THE COMPENSATION OF THE OTHER OFFICERS. THIS PROCESS FOR THE 2024 SALARIES WAS CONDUCTED IN NOVEMBER 2023. SUBSEQUENTLY ANOTHER REVIEW WAS DONE IN OCTOBER 2024 FOR THE 2025 SALARIES. Form 990, Part VI, Line 15b Process to establish compensation of other employees NOVEMBER 2023 - COMPENSATION COMMITTEE. SUBSEQUENTLY ANOTHER REVIEW WAS DONE IN OCTOBER 2024 FOR THE 2025 SALARIES. Form 990, Part VI, Line 19 Required documents available to the public MEMBERS OF THE PUBLIC MAY REQUEST A COPY OF THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS BY PHONE, EMAIL OR MAIL. COPIES OF THE REQUESTED DOCUMENTS ARE SENT TO THEM VIA THE MEDIUM OF THEIR CHOICE. Form 990, Part IX, Line 11g Other Fees SUB-CONTRACTS - Total Expense: 3002950, Program Service Expense: 3002950, Management and General Expenses: , Fundraising Expenses: ; CONSULTANTS - Total Expense: 2865403, Program Service Expense: 2098542, Management and General Expenses: 479283, Fundraising Expenses: 287578; RECRUITMENT COSTS - Total Expense: 434662, Program Service Expense: 318334, Management and General Expenses: 72704, Fundraising Expenses: 43624; TEMPORARY HELP - Total Expense: 105886, Program Service Expense: 77548, Management and General Expenses: 17711, Fundraising Expenses: 10627; Mailing House Services - Total Expense: 143366, Program Service Expense: 104997, Management and General Expenses: 23980, Fundraising Expenses: 14389; Form 990, Part XI, Line 9 Other changes in net assets or fund balances CHANGE IN POSTRETIREMENT BENEFITS - 99366; FORM 990, PAGE 1, BOX G FROM PART VIII - STATEMENT OF REVENUE THE BREAKDOWN OF GUTTMACHER'S REVENUE FOR 2024 IS AS FOLLOWS: CONTRIBUTIONS/ GRANTS $ 23,313,235 PUBLICATIONS $ 14,211 INVESTMENT INCOME $ 1,447,117 ROYALTIES $ 16,625 GROSS SALES OF INVESTMENTS $ 40,700,303 OTHER $ 290,212 -------------------------------------------------------------------- TOTAL PER PAGE 1 $ 65,781,703